These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
469 related articles for article (PubMed ID: 18845809)
1. Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Mercure C; Yogi A; Callera GE; Aranha AB; Bader M; Ferreira AJ; Santos RA; Walther T; Touyz RM; Reudelhuber TL Circ Res; 2008 Nov; 103(11):1319-26. PubMed ID: 18845809 [TBL] [Abstract][Full Text] [Related]
2. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice. Patel VB; Bodiga S; Fan D; Das SK; Wang Z; Wang W; Basu R; Zhong J; Kassiri Z; Oudit GY Hypertension; 2012 Jun; 59(6):1195-203. PubMed ID: 22508831 [TBL] [Abstract][Full Text] [Related]
3. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme. Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786 [TBL] [Abstract][Full Text] [Related]
4. Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats. Trask AJ; Averill DB; Ganten D; Chappell MC; Ferrario CM Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3019-24. PubMed ID: 17308000 [TBL] [Abstract][Full Text] [Related]
5. Activation of angiotensin-(1-7)/Mas axis in the brain lowers blood pressure and attenuates cardiac remodeling in hypertensive transgenic (mRen2)27 rats. Kangussu LM; Guimaraes PS; Nadu AP; Melo MB; Santos RA; Campagnole-Santos MJ Neuropharmacology; 2015 Oct; 97():58-66. PubMed ID: 25983274 [TBL] [Abstract][Full Text] [Related]
7. ACE2 of the heart: From angiotensin I to angiotensin (1-7). Keidar S; Kaplan M; Gamliel-Lazarovich A Cardiovasc Res; 2007 Feb; 73(3):463-9. PubMed ID: 17049503 [TBL] [Abstract][Full Text] [Related]
8. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice. Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats. Trask AJ; Groban L; Westwood BM; Varagic J; Ganten D; Gallagher PE; Chappell MC; Ferrario CM Am J Hypertens; 2010 Jun; 23(6):687-93. PubMed ID: 20300067 [TBL] [Abstract][Full Text] [Related]
11. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Kassiri Z; Zhong J; Guo D; Basu R; Wang X; Liu PP; Scholey JW; Penninger JM; Oudit GY Circ Heart Fail; 2009 Sep; 2(5):446-55. PubMed ID: 19808375 [TBL] [Abstract][Full Text] [Related]
12. Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure. Iwata M; Cowling RT; Yeo SJ; Greenberg B J Mol Cell Cardiol; 2011 Oct; 51(4):542-7. PubMed ID: 21147120 [TBL] [Abstract][Full Text] [Related]
13. Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling. Sato T; Kadowaki A; Suzuki T; Ito H; Watanabe H; Imai Y; Kuba K Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634441 [TBL] [Abstract][Full Text] [Related]
14. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling. Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246 [TBL] [Abstract][Full Text] [Related]
15. Role of angiotensin-converting enzyme 2 in cardiac hypertrophy induced by nitric oxide synthase inhibition. Inaba S; Iwai M; Furuno M; Kanno H; Senba I; Okayama H; Mogi M; Higaki J; Horiuchi M J Hypertens; 2011 Nov; 29(11):2236-45. PubMed ID: 21946695 [TBL] [Abstract][Full Text] [Related]
16. Role of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis in the hypotensive effect of azilsartan. Iwanami J; Mogi M; Tsukuda K; Wang XL; Nakaoka H; Ohshima K; Chisaka T; Bai HY; Kanno H; Min LJ; Horiuchi M Hypertens Res; 2014 Jul; 37(7):616-20. PubMed ID: 24599018 [TBL] [Abstract][Full Text] [Related]
17. Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. Gurley SB; Allred A; Le TH; Griffiths R; Mao L; Philip N; Haystead TA; Donoghue M; Breitbart RE; Acton SL; Rockman HA; Coffman TM J Clin Invest; 2006 Aug; 116(8):2218-25. PubMed ID: 16878172 [TBL] [Abstract][Full Text] [Related]
19. Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade. Ohshima K; Mogi M; Nakaoka H; Iwanami J; Min LJ; Kanno H; Tsukuda K; Chisaka T; Bai HY; Wang XL; Ogimoto A; Higaki J; Horiuchi M Hypertension; 2014 Mar; 63(3):e53-9. PubMed ID: 24379178 [TBL] [Abstract][Full Text] [Related]